Medical Doctor Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Vijay Raj

Pain Medicine Brookline, MA Medical Doctor

NPI 1396308078 CMS profile 11631438

1 Brookline Pl Ste 105, Brookline, MA 02445

Open in the dashboard

General payments

$4,048

30 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vijay Raj of Brookline, MA is reported in the CMS Open Payments database as having received $4,048 across 30 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,401 14
2024 General $2,647 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vijay Raj
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Vijay Raj were reported at $1,401. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Vijay Raj Pain Medicine median Middle half National median
2019 $0 $506 $144–$1,566 $163
2020 $0 $315 $96–$934 $114
2021 $0 $452 $134–$1,237 $132
2022 $0 $475 $124–$1,407 $149
2023 $0 $480 $136–$1,384 $160
2024 $2,647 $521 $164–$1,511 $164
2025 $1,401 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Boston Scientific Corporation $1,921 12 payments
  2. Medtronic, Inc. $828 6 payments
  3. Saluda Medical Americas, Inc. $362 2 payments
  4. Teva Pharmaceuticals USA, Inc. $267 2 payments
  5. Nevro Corp. $199 4 payments
  6. Averitas Pharma Inc. $150 1 payment
  7. Globus Medical, Inc. $126 1 payment
  8. MML US, Inc. $106 1 payment
  9. Painteq LLC $88 1 payment

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Travel and Lodging $2,127 11 payments
  2. Food and Beverage $1,922 19 payments
Products named General payments · program years 2024–2025
  1. WaveWriter Alpha Prime 16 $1,204 10 payments
  2. INTELLIS ADAPTIVESTIM $828 6 payments
  3. Evoke $362 2 payments
  4. AJOVY $267 2 payments
  5. Senza Spinal Cord Stimulator $199 4 payments
  6. Qutenza $150 1 payment
  7. Senza Spinal Cord Stimulator $126 1 payment
  8. ReActiv8 $106 1 payment
  9. PAINTEQ $88 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

44

Median for Anesthesiology: 322

Drug cost

$440

Median for Anesthesiology: $8,738

Branded share of claims

0%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 29 $331
Pregabalin Generic 15 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$14,245

Medicare's payments for the services billed

Medicare patients

84

Average age 74

Services billed

122

43 women, 41 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 55%
Diabetes 32%
Ischemic heart disease 29%
Chronic kidney disease 27%
Depression 27%
Atrial fibrillation 26%
Heart failure 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
AJOVY
  • Teva Pharmaceuticals USA, Inc. $267
$267 — —
Qutenza
  • Averitas Pharma Inc. $150
$150 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

30 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record